These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35411578)

  • 1. Anti-IL23for nail psoriasis in real life: Results of efficacy and safety during a 52-week period.
    Trovato E; Cortonesi G; Orsini C; Capalbo E; Cinotti E; Rubegni P; Cartocci A
    Dermatol Ther; 2022 Jul; 35(7):e15506. PubMed ID: 35411578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy.
    Kokolakis G; Bachmann F; Wolk K; Sabat R; Philipp S
    Acta Derm Venereol; 2020 Jul; 100(14):adv00214. PubMed ID: 32511739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for nail psoriasis.
    de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007633. PubMed ID: 23440816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
    Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
    Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result.
    Ricceri F; Pescitelli L; Tripo L; Bassi A; Prignano F
    Dermatol Ther; 2013; 26(1):77-8. PubMed ID: 23384024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study.
    Gümüşel M; Özdemir M; Mevlitoğlu I; Bodur S
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1080-4. PubMed ID: 21118309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis.
    Merola JF; Elewski B; Tatulych S; Lan S; Tallman A; Kaur M
    J Am Acad Dermatol; 2017 Jul; 77(1):79-87.e1. PubMed ID: 28396102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus.
    Rigopoulos D; Baran R; Chiheb S; Daniel CR; Di Chiacchio N; Gregoriou S; Grover C; Haneke E; Iorizzo M; Pasch M; Piraccini BM; Rich P; Richert B; Rompoti N; Rubin AI; Singal A; Starace M; Tosti A; Triantafyllopoulou I; Zaiac M
    J Am Acad Dermatol; 2019 Jul; 81(1):228-240. PubMed ID: 30731172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secukinumab efficacy in the treatment of nail psoriasis: a case series.
    Pistone G; Gurreri R; Tilotta G; Castelli E; Bongiorno MR
    J Dermatolog Treat; 2018; 29(sup1):21-24. PubMed ID: 30273068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial.
    Reich K; Sullivan J; Arenberger P; Mrowietz U; Jazayeri S; Augustin M; Parneix A; Regnault P; You R; Milutinovic M
    Br J Dermatol; 2019 Nov; 181(5):954-966. PubMed ID: 30367462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutics for Adult Nail Psoriasis and Nail Lichen Planus: A Guide for Clinicians.
    McClanahan DR; English JC
    Am J Clin Dermatol; 2018 Aug; 19(4):559-584. PubMed ID: 29488102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study.
    Rigopoulos D; Gregoriou S; Makris M; Ioannides D
    Dermatology; 2011; 223(4):325-9. PubMed ID: 22134046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis.
    Reich K; Conrad C; Kristensen LE; Smith SD; Puig L; Rich P; Sapin C; Holzkaemper T; Koppelhus U; Schuster C
    J Dermatolog Treat; 2022 May; 33(3):1652-1660. PubMed ID: 33641593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.
    Elewski BE; Okun MM; Papp K; Baker CS; Crowley JJ; Guillet G; Sundaram M; Poulin Y; Gu Y; Geng Z; Williams DA; Rich PA
    J Am Acad Dermatol; 2018 Jan; 78(1):90-99.e1. PubMed ID: 28993005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3.
    Egeberg A; Kristensen LE; Vender R; Zaheri S; El Baou C; Gallo G; Riedl E; Schuster C
    Acta Derm Venereol; 2022 Oct; 102():adv00787. PubMed ID: 36121210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of psoriatic crumbly nails with ustekinumab.
    Galluzzo M; D'Adamio S; Chimenti MS; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12914. PubMed ID: 30968520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of Nail and Scalp Psoriasis Using Apremilast in Patients With Chronic Psoriasis: Phase 2b and 3, 52-Week Randomized, Placebo-Controlled Trial Results.
    Nguyen CM; Leon A; Danesh M; Beroukhim K; Wu JJ; Koo J
    J Drugs Dermatol; 2016 Mar; 15(3):272-6. PubMed ID: 26954311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis.
    Gallo G; Mastorino L; Barilà D; Cattel F; Panzone M; Quaglino P; Ribero S; Dapavo P
    Dermatol Ther; 2022 Dec; 35(12):e15917. PubMed ID: 36214268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ixekizumab Is Effective in Subjects With Moderate to Severe Plaque Psoriasis With Significant Nail Involvement: Results From UNCOVER 3.
    Dennehy EB; Zhang L; Amato D; Goldblum O; Rich P
    J Drugs Dermatol; 2016 Aug; 15(8):958-61. PubMed ID: 27537996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.